• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2017)
Zaghary, W., Motaleb, M., Ibrahim, I., Sarhan, M. (2018). Preparation, Biodistribution of 99mTc-Azacytidine Complex as a Potential Agent for Radiotherapy. Journal of Advanced Pharmacy Research, 2(1), 63-72. doi: 10.21608/aprh.2018.4835
Wafaa A. Zaghary; Mohammed A. Motaleb; Ismail T. Ibrahim; Mona O. Sarhan. "Preparation, Biodistribution of 99mTc-Azacytidine Complex as a Potential Agent for Radiotherapy". Journal of Advanced Pharmacy Research, 2, 1, 2018, 63-72. doi: 10.21608/aprh.2018.4835
Zaghary, W., Motaleb, M., Ibrahim, I., Sarhan, M. (2018). 'Preparation, Biodistribution of 99mTc-Azacytidine Complex as a Potential Agent for Radiotherapy', Journal of Advanced Pharmacy Research, 2(1), pp. 63-72. doi: 10.21608/aprh.2018.4835
Zaghary, W., Motaleb, M., Ibrahim, I., Sarhan, M. Preparation, Biodistribution of 99mTc-Azacytidine Complex as a Potential Agent for Radiotherapy. Journal of Advanced Pharmacy Research, 2018; 2(1): 63-72. doi: 10.21608/aprh.2018.4835

Preparation, Biodistribution of 99mTc-Azacytidine Complex as a Potential Agent for Radiotherapy

Article 7, Volume 2, Issue 1, January 2018, Page 63-72  XML PDF (387.29 K)
Document Type: Research Article
DOI: 10.21608/aprh.2018.4835
View on SCiNiTO View on SCiNiTO
Authors
Wafaa A. Zaghary1; Mohammed A. Motaleb2; Ismail T. Ibrahim2; Mona O. Sarhan email 2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Cairo11795, Egypt
2Labelled Compounds Department, Hot Lab Centre, Egyptian Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt
Abstract
Objectives: This study aimed at exploring the possibility of radiolabeling 5-Azacytidine with technetium-99m (99mTc) as a surrogate for Rhenium- 186/188 in order to explore the possibility of using the radiolabeled complex as a targeted radiotherapeutic agent. Methods: Radiolabeling of 5-Azacytidine with 99mTc via complexation reaction using stannous chloride dihydrate as a reducing agent. The biodistribution of the formed complex was then studied in tumour bearing mice. Results: Successful radiolabeling of 5-Azacytidine with 99mTc was achieved with radiolabeling yield 84.94%. The formed complex showed in vitro stability up to 60 min post labelling. The biodistribution study of the complex showed a Target /Non-target ratio of 2.27 at 2h post injection suggesting good localization of the complex. Conclusion: The radiolabeling of 5-Aza was successfully achieved with 99mTc. The biodistribution study in tumour bearing mice showed good localization of the radiolabeled complex at the tumour site, however further studies are needed for achieving better targeting of the complex.
Keywords
5-azacytidine; Biodistribution; Radiolabeling; Radiochemotherapy; 99mTc
Statistics
Article View: 339
PDF Download: 706
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.